Virtu Financial’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Virtu Financial’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-156,259	Closed	-$50K	–	2789
2018 Q1	$50K	Buy	156,259 +145,701	+1,380%	+$218K	﹤0.01%	1719
2017 Q4	$17K	Buy	+10,558	New	+$18.2K	﹤0.01%	2238

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Virtu Financial's ANTH Position: Q2 2018 in Review

Virtu Financial sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 156,259 shares — an estimated $50K sold.

Virtu Financial first reported a position in ANTH in Q4 2017 and held it in 2 quarters. The position peaked at $50K in Q1 2018. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

Virtu Financial reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Virtu Financial sold 156,259 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $50K.
Virtu Financial first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
Virtu Financial's Anthera Pharmaceuticals, Inc. position peaked at $50K in Q1 2018.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.